Clinical trial
Application of Pericapsular Nerve Group (PENG) Block in Transurethral Resection of Bladder Tumors
NCT07078773 is registered in ClinicalTrials.gov with Nanjing First Hospital, Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Application of Pericapsular Nerve Group (PENG) Block in Transurethral Resection of Bladder Tumors
- Lead sponsor
- Nanjing First Hospital, Nanjing Medical University
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- July 12, 2025
- Completion date
- December 31, 2026
- Enrollment
- 68 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
turbt